Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,686.80 -574.26 -2.47%
S&P/ASX 200 5,062.40 -102.97 -1.99%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Credit Suisse SICAV Lux Equity Biotechnology

+ Add to Watchlist

CLABIOT:LX

255.00 USD 0.25 0.10%

As of 00:59:30 ET on 05/21/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Credit Suisse SICAV Lux Equity Biotechnology (CLABIOT)

Year To Date: +29.54% 3-Month: +23.47% 3-Year: +28.91% 52-Week Range: 170.55 - 262.08
1-Month: +3.60% 1-Year: +43.66% 5-Year: +14.66% Beta vs NBI: 1.03

Mutual Fund Chart for CLABIOT

No chart data available.
  • CLABIOT:LX 255.00
  • 1M
  • 1Y
Interactive CLABIOT Chart

Previous Close

Fund Profile & Information for CLABIOT

Credit Suisse SICAV (Lux) Equity Biotechnology is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in a portfolio of equity securities of biotechnology companies worldwide.

Inception Date: 11-06-2001 Telephone: -
Managers: IRENE B PUTTNER
Web Site: www.credit-suisse.com

Fundamentals for CLABIOT

NAV (on 2013-05-21) 255.00
Assets (M) (on 2013-05-21) 169.34
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for CLABIOT

No dividends reported

Fees & Expenses for CLABIOT

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CLABIOT

Filing Date: 03/27/2013
Name Position Value % of Total
Gilead Sciences Inc 260,484 12,430,296 8.108%
Celgene Corp 107,638 12,188,927 7.951%
Biogen Idec Inc 52,745 9,635,457 6.285%
Amgen Inc 84,973 8,510,046 5.551%
BioMarin Pharmaceutical Inc 130,444 7,873,600 5.136%
Vertex Pharmaceuticals Inc 141,000 7,731,030 5.043%
Onyx Pharmaceuticals Inc 85,000 7,525,050 4.908%
Regeneron Pharmaceuticals Inc 44,000 7,519,600 4.905%
Alexion Pharmaceuticals Inc 74,752 7,020,708 4.580%
Incyte Corp Ltd 265,000 6,007,550 3.919%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil